Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The blunted beta adrenoceptor-mediated PKA response in fibroblasts from patients with major depression is reflected in a significant reduction in the isoproterenol-stimulated phosphorylation of the nuclear transcription factor CREB.
|
11099740 |
2000 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression.
|
12457397 |
2002 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
This 451 kb region includes CREB1, an attractive susceptibility gene for MDD and related disorders.
|
12851637 |
2003 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.
|
17258370 |
2007 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Therefore, we examined the association between CREB1 polymorphisms and anger expression in MDD.
|
17300755 |
2007 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we examined the association between CREB1 polymorphisms and anger expression in MDD.
|
17300755 |
2007 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
To examine polymorphisms that span CREB1, which was previously associated with anger expression in men with major depressive disorder, for association with new or worsening suicidality.
|
17548750 |
2007 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The results support the hypothesis that the A(-656) allele contributes to the development of MDD in women by selectively altering the activity of the CREB1 promoter in glial cells exposed to 17 beta-estradiol.
|
18213625 |
2008 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The results support the hypothesis that the A(-656) allele contributes to the development of MDD in women through selective alteration of CREB1 promoter activity by female gonadal steroids in noradrenergic neuronal cells.
|
18317463 |
2009 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A polymorphism near the cyclic adenosine monophosphate response element binding protein gene (CREB1) has recently been associated with greater self-reported effort at anger control as well as risk for antidepressant treatment-emergent suicidality in men with major depressive disorder, but its functional effects have not been studied.
|
18678793 |
2008 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data suggests that common variations in the CREB1 gene do not appear to increase susceptibility for MDD or related phenotypes.
|
19194961 |
2009 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The results continue to support sex-specific linkage of the CREB1 region to mood disorders among women from families with RE-MDD.
|
19517574 |
2010 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to investigate the potential association of a set of single nucleotide polymorphisms (SNPs) in CREB1 gene and both MD and response, remission and treatment resistance to antidepressants.
|
20643483 |
2011 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Results from previous transfection experiments that employed constructs containing the wild-type or variant CREB1 promoters coupled to a reporter gene support the hypothesis that the A(-656) allele contributes to the development of MDD in women by selectively increasing the activity of the CREB1 promoter in brain cell lines exposed to 17 β-estradiol.
|
20957653 |
2010 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The recombinant strain exhibited decreases in reproductive capacity and pup survival that may be related to increased infant mortality observed in RE-MDD families; enlargement of the cerebral ventricles; reduced levels of CREB protein in the mouse cerebral cortex, as predicted from transfection experiments employing the pathogenic human CREB1 promoter; and alterations in two standardized behavioral tests, the forced swim and marble burying tests.
|
21598377 |
2011 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
IFN-α-treated patients with high depression/fatigue scores demonstrated up-regulation of genes bearing promoter motifs for transcription factors involved in myeloid differentiation, IFN-α and AP1 signaling, and reduced prevalence of motifs for CREB/ATF, which has been implicated in major depression.
|
22152193 |
2012 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This was achieved by replacing the corresponding mouse DNA sequence with a 6-base DNA sequence from the human CREB1 promoter that is associated with the development of MDD in families identified by probands with recurrent, early-onset MDD.
|
22180334 |
2012 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Recently, an increasing number of studies focused on the role of cyclic adenosine monophosphate response element binding protein 1 (CREB1) and Piccolo (PCLO) on MDD.
|
22293360 |
2012 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
|
22386572 |
2012 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
To explore the possible relationship between six single nucleotide polymorphisms (SNPs) (rs6311 and rs6305 of 5-HT2A, rs5443 of Gβ3, rs2230739 of ACDY9, rs1549870 of PDE1A and rs255163 of CREB1, which are all related with 5-HT2A the signal transduction pathway) and the response efficacy to selective serotonin reuptake inhibitor (SSRI) treatments in major depressive disorder (MDD) Chinese.
|
22480177 |
2012 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The primary aim of this study was to investigate whether a set of single nucleotide polymorphisms (SNPs) within two genes implicated in neuroplasticity and inflammatory processes (the mitogen activated protein kinase 1, MAPK1 (rs3810608, rs6928, rs13515 and rs8136867), and the cyclic AMP responsive element binding protein 1, CREB1 (rs889895, rs6740584, rs2551922 and rs2254137)) was associated with antidepressant treatment resistance (according to two different definitions), in 285 Major Depressive Disorder (MDD) patients.
|
23537502 |
2013 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Here, we studied the MDD-related gene CREB1 in a set of independent BD sample groups of European ancestry (a total of 64,888 subjects) and identified multiple SNPs significantly associated with BD (the most significant being SNP rs6785[A], P=6.32 × 10(-5), odds ratio (OR)=1.090).
|
23568192 |
2014 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This study aimed to investigate the influence of CREB1 polymorphism on cognitive function in patients with MDD.
|
23844928 |
2014 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
This study aimed to investigate the influence of CREB1 polymorphism on cognitive function in patients with MDD.
|
23844928 |
2014 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This was achieved by replacing the corresponding mouse DNA sequence with a 6-base DNA sequence from the human CREB1 promoter that is associated with the development of MDD in men and women from families identified by probands with recurrent, early-onset MDD (RE-MDD).
|
24006268 |
2014 |